| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 18 | 2020 | 833 | 1.710 |
Why?
|
| Energy Metabolism | 21 | 2006 | 765 | 1.140 |
Why?
|
| Enteral Nutrition | 6 | 2014 | 259 | 0.840 |
Why?
|
| Sucking Behavior | 4 | 2012 | 21 | 0.830 |
Why?
|
| Milk, Human | 22 | 2012 | 300 | 0.790 |
Why?
|
| Adipose Tissue | 20 | 2006 | 465 | 0.750 |
Why?
|
| Body Composition | 22 | 2005 | 521 | 0.710 |
Why?
|
| Infant, Newborn | 71 | 2020 | 8273 | 0.700 |
Why?
|
| Body Weight | 29 | 2014 | 989 | 0.690 |
Why?
|
| Lactation | 13 | 2007 | 192 | 0.670 |
Why?
|
| Obesity | 17 | 2014 | 2252 | 0.630 |
Why?
|
| Breast Feeding | 20 | 2000 | 221 | 0.620 |
Why?
|
| Swine | 11 | 2008 | 1179 | 0.600 |
Why?
|
| Isoflavones | 4 | 2013 | 43 | 0.600 |
Why?
|
| Feeding Behavior | 6 | 2012 | 699 | 0.570 |
Why?
|
| Female | 167 | 2020 | 66815 | 0.570 |
Why?
|
| Mothers | 1 | 2020 | 356 | 0.550 |
Why?
|
| Stress, Psychological | 2 | 2020 | 550 | 0.530 |
Why?
|
| Self Concept | 2 | 2016 | 153 | 0.520 |
Why?
|
| beta-Glucans | 3 | 2013 | 17 | 0.520 |
Why?
|
| Parenting | 1 | 2020 | 333 | 0.520 |
Why?
|
| Minority Groups | 3 | 2016 | 243 | 0.500 |
Why?
|
| Postpartum Period | 5 | 2003 | 216 | 0.480 |
Why?
|
| Humans | 209 | 2020 | 125358 | 0.460 |
Why?
|
| Male | 128 | 2024 | 61561 | 0.450 |
Why?
|
| Infant Food | 10 | 2010 | 81 | 0.440 |
Why?
|
| Indians, North American | 5 | 1997 | 58 | 0.430 |
Why?
|
| Deglutition | 2 | 2012 | 51 | 0.430 |
Why?
|
| Dietary Supplements | 5 | 2013 | 472 | 0.430 |
Why?
|
| Energy Intake | 12 | 2004 | 493 | 0.420 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2017 | 205 | 0.420 |
Why?
|
| Infant | 74 | 2020 | 12601 | 0.410 |
Why?
|
| Basal Metabolism | 9 | 2003 | 95 | 0.400 |
Why?
|
| Lactose | 3 | 2005 | 54 | 0.400 |
Why?
|
| Adolescent | 66 | 2019 | 19423 | 0.400 |
Why?
|
| Postmenopause | 2 | 2010 | 126 | 0.390 |
Why?
|
| Pacifiers | 1 | 2012 | 5 | 0.390 |
Why?
|
| Rett Syndrome | 4 | 2009 | 292 | 0.380 |
Why?
|
| Intestinal Mucosa | 3 | 2005 | 781 | 0.370 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 2000 | 62 | 0.360 |
Why?
|
| Body Mass Index | 12 | 2016 | 1563 | 0.360 |
Why?
|
| Growth | 9 | 2000 | 106 | 0.360 |
Why?
|
| Lactase | 3 | 2010 | 40 | 0.360 |
Why?
|
| Child | 69 | 2019 | 24606 | 0.360 |
Why?
|
| Adipocytes | 7 | 2005 | 141 | 0.350 |
Why?
|
| Gastrointestinal Contents | 1 | 2010 | 13 | 0.350 |
Why?
|
| Eating | 4 | 2010 | 369 | 0.350 |
Why?
|
| Motor Skills | 1 | 2011 | 83 | 0.350 |
Why?
|
| Gestational Age | 14 | 2018 | 1169 | 0.340 |
Why?
|
| Bone Density | 3 | 2009 | 319 | 0.340 |
Why?
|
| Adult | 64 | 2020 | 29540 | 0.330 |
Why?
|
| Prospective Studies | 26 | 2019 | 6142 | 0.320 |
Why?
|
| Child Development | 6 | 2012 | 269 | 0.320 |
Why?
|
| Infant Formula | 2 | 2012 | 97 | 0.320 |
Why?
|
| Cholesterol, Dietary | 2 | 2008 | 46 | 0.320 |
Why?
|
| Enterocolitis, Necrotizing | 6 | 2014 | 245 | 0.310 |
Why?
|
| Folic Acid | 2 | 2009 | 293 | 0.310 |
Why?
|
| Betaine | 1 | 2009 | 22 | 0.310 |
Why?
|
| Child, Preschool | 55 | 2017 | 14145 | 0.310 |
Why?
|
| Probiotics | 1 | 2012 | 215 | 0.310 |
Why?
|
| Pregnancy | 26 | 2018 | 7226 | 0.310 |
Why?
|
| Thinness | 2 | 2014 | 71 | 0.310 |
Why?
|
| Birth Weight | 9 | 2007 | 346 | 0.300 |
Why?
|
| Metabolic Syndrome | 4 | 2005 | 342 | 0.290 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 34 | 0.290 |
Why?
|
| Receptors, Purinergic P1 | 2 | 1997 | 10 | 0.290 |
Why?
|
| Cerebrum | 1 | 2008 | 37 | 0.290 |
Why?
|
| Infant, Premature, Diseases | 3 | 2014 | 245 | 0.280 |
Why?
|
| Umbilical Arteries | 3 | 2004 | 98 | 0.270 |
Why?
|
| Cholesterol | 2 | 2008 | 541 | 0.260 |
Why?
|
| Nutritional Requirements | 7 | 2016 | 181 | 0.250 |
Why?
|
| Texas | 18 | 2017 | 3581 | 0.250 |
Why?
|
| Pregnancy in Adolescence | 1 | 2006 | 50 | 0.250 |
Why?
|
| Milk Banks | 1 | 2005 | 4 | 0.250 |
Why?
|
| Infant, Very Low Birth Weight | 5 | 2014 | 173 | 0.250 |
Why?
|
| Minerals | 3 | 2000 | 59 | 0.240 |
Why?
|
| Depression, Postpartum | 1 | 2006 | 51 | 0.240 |
Why?
|
| Models, Biological | 8 | 2002 | 1465 | 0.240 |
Why?
|
| Behavior, Animal | 1 | 2008 | 491 | 0.240 |
Why?
|
| Bottle Feeding | 5 | 2011 | 36 | 0.240 |
Why?
|
| Lenses | 1 | 2004 | 5 | 0.240 |
Why?
|
| Mass Screening | 5 | 2016 | 785 | 0.230 |
Why?
|
| Catheterization, Peripheral | 2 | 2004 | 124 | 0.220 |
Why?
|
| Optic Disk | 1 | 2024 | 44 | 0.220 |
Why?
|
| Double-Blind Method | 9 | 2019 | 1634 | 0.220 |
Why?
|
| Diet | 8 | 2016 | 1138 | 0.220 |
Why?
|
| Body Water | 9 | 2003 | 90 | 0.220 |
Why?
|
| Graft Rejection | 5 | 2012 | 588 | 0.210 |
Why?
|
| Animal Nutritional Physiological Phenomena | 2 | 2008 | 63 | 0.210 |
Why?
|
| School Health Services | 4 | 2016 | 99 | 0.210 |
Why?
|
| Retinal Ganglion Cells | 1 | 2024 | 99 | 0.210 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2012 | 149 | 0.210 |
Why?
|
| Nitrogen | 6 | 2001 | 145 | 0.210 |
Why?
|
| Heart Transplantation | 5 | 2008 | 859 | 0.210 |
Why?
|
| Macaca mulatta | 1 | 2024 | 490 | 0.200 |
Why?
|
| Weaning | 3 | 1997 | 44 | 0.200 |
Why?
|
| Anthropometry | 9 | 2003 | 197 | 0.200 |
Why?
|
| Menopause | 2 | 2013 | 75 | 0.200 |
Why?
|
| Motor Activity | 3 | 2011 | 521 | 0.190 |
Why?
|
| Potassium | 6 | 2000 | 285 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2014 | 817 | 0.190 |
Why?
|
| Time Factors | 20 | 2014 | 6311 | 0.190 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2012 | 40 | 0.190 |
Why?
|
| Weight Gain | 3 | 2003 | 400 | 0.190 |
Why?
|
| Risk Factors | 26 | 2016 | 10296 | 0.180 |
Why?
|
| Age Factors | 18 | 2014 | 2818 | 0.180 |
Why?
|
| Mucin-1 | 3 | 2010 | 35 | 0.180 |
Why?
|
| Severity of Illness Index | 12 | 2014 | 2909 | 0.180 |
Why?
|
| Intestine, Small | 2 | 2005 | 310 | 0.180 |
Why?
|
| Reproduction | 1 | 2003 | 236 | 0.180 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2008 | 313 | 0.170 |
Why?
|
| Physical Exertion | 2 | 1999 | 78 | 0.170 |
Why?
|
| Longitudinal Studies | 15 | 2010 | 1320 | 0.170 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2009 | 259 | 0.170 |
Why?
|
| Calcification, Physiologic | 1 | 2000 | 22 | 0.170 |
Why?
|
| Tuberculosis | 2 | 2016 | 527 | 0.170 |
Why?
|
| Plant Extracts | 2 | 2012 | 119 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 6 | 2008 | 1123 | 0.170 |
Why?
|
| Sleep | 3 | 2013 | 346 | 0.170 |
Why?
|
| Colitis, Ulcerative | 2 | 2014 | 208 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2009 | 216 | 0.160 |
Why?
|
| beta-Galactosidase | 2 | 1998 | 147 | 0.160 |
Why?
|
| Mother-Child Relations | 1 | 2020 | 78 | 0.160 |
Why?
|
| Early Diagnosis | 1 | 2020 | 184 | 0.160 |
Why?
|
| Myopia, Degenerative | 1 | 2019 | 9 | 0.160 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2019 | 22 | 0.160 |
Why?
|
| Lung Transplantation | 3 | 2012 | 323 | 0.160 |
Why?
|
| Oxygen Consumption | 4 | 2003 | 305 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 527 | 0.160 |
Why?
|
| Exercise | 7 | 2016 | 814 | 0.160 |
Why?
|
| Puberty | 2 | 1999 | 95 | 0.160 |
Why?
|
| Animals, Suckling | 2 | 1999 | 50 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2011 | 157 | 0.150 |
Why?
|
| Niacin | 2 | 2011 | 58 | 0.150 |
Why?
|
| Pertussis Toxin | 1 | 2018 | 28 | 0.150 |
Why?
|
| Fenofibrate | 2 | 2011 | 59 | 0.150 |
Why?
|
| Aging | 5 | 2007 | 1182 | 0.150 |
Why?
|
| Insulin | 6 | 2013 | 1203 | 0.150 |
Why?
|
| Biomarkers | 8 | 2014 | 3106 | 0.150 |
Why?
|
| Analysis of Variance | 11 | 2019 | 1017 | 0.150 |
Why?
|
| Predictive Value of Tests | 13 | 2014 | 2182 | 0.150 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2018 | 35 | 0.150 |
Why?
|
| Proteins | 3 | 2004 | 1039 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2000 | 266 | 0.140 |
Why?
|
| Whooping Cough | 1 | 2018 | 60 | 0.140 |
Why?
|
| Antibodies, Bacterial | 3 | 2018 | 390 | 0.140 |
Why?
|
| Cross-Sectional Studies | 11 | 2014 | 3407 | 0.140 |
Why?
|
| Regression Analysis | 12 | 2007 | 778 | 0.140 |
Why?
|
| Poverty | 4 | 2016 | 421 | 0.140 |
Why?
|
| Students | 2 | 2016 | 247 | 0.140 |
Why?
|
| Treatment Outcome | 22 | 2014 | 12287 | 0.140 |
Why?
|
| Reference Values | 9 | 2014 | 719 | 0.140 |
Why?
|
| Dietary Fats | 5 | 2006 | 294 | 0.140 |
Why?
|
| Cardiac Output | 2 | 1988 | 170 | 0.140 |
Why?
|
| Infant Nutritional Physiological Phenomena | 7 | 2007 | 193 | 0.140 |
Why?
|
| Retrospective Studies | 28 | 2017 | 16363 | 0.140 |
Why?
|
| Calorimetry, Indirect | 5 | 2003 | 56 | 0.140 |
Why?
|
| Natriuretic Agents | 2 | 2007 | 33 | 0.130 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 3689 | 0.130 |
Why?
|
| Placebos | 5 | 2013 | 241 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 292 | 0.130 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 16 | 0.130 |
Why?
|
| Sex Reassignment Procedures | 1 | 2016 | 15 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2014 | 81 | 0.130 |
Why?
|
| Breath Tests | 6 | 2009 | 178 | 0.130 |
Why?
|
| Follow-Up Studies | 16 | 2014 | 5171 | 0.130 |
Why?
|
| Splanchnic Circulation | 2 | 2014 | 53 | 0.120 |
Why?
|
| Animals, Newborn | 5 | 2008 | 1018 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 1998 | 384 | 0.120 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2010 | 207 | 0.120 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2009 | 310 | 0.120 |
Why?
|
| Hospitals, Pediatric | 4 | 2014 | 766 | 0.120 |
Why?
|
| Community Health Services | 1 | 2016 | 88 | 0.120 |
Why?
|
| Staphylococcal Infections | 3 | 2012 | 562 | 0.120 |
Why?
|
| Hyperglycemia | 2 | 2008 | 227 | 0.120 |
Why?
|
| Blood Glucose | 5 | 2008 | 1134 | 0.120 |
Why?
|
| Calorimetry | 5 | 2006 | 62 | 0.120 |
Why?
|
| Oxygen | 4 | 2014 | 556 | 0.120 |
Why?
|
| Health Education | 1 | 2016 | 221 | 0.120 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 168 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 112 | 0.120 |
Why?
|
| Residence Characteristics | 2 | 2014 | 273 | 0.120 |
Why?
|
| Blood Pressure | 5 | 2012 | 1377 | 0.120 |
Why?
|
| Methotrexate | 1 | 2017 | 336 | 0.110 |
Why?
|
| Lipid Metabolism | 4 | 2006 | 357 | 0.110 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 175 | 0.110 |
Why?
|
| Absorptiometry, Photon | 5 | 2002 | 178 | 0.110 |
Why?
|
| Lactose Intolerance | 3 | 2005 | 9 | 0.110 |
Why?
|
| Gastroenterology | 1 | 2017 | 201 | 0.110 |
Why?
|
| Catecholamines | 2 | 1999 | 59 | 0.110 |
Why?
|
| Swine Diseases | 3 | 1999 | 37 | 0.110 |
Why?
|
| Referral and Consultation | 2 | 2017 | 543 | 0.110 |
Why?
|
| Larynx, Artificial | 1 | 2013 | 4 | 0.110 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 24 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2017 | 732 | 0.110 |
Why?
|
| Forced Expiratory Volume | 2 | 2012 | 171 | 0.110 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 8 | 0.110 |
Why?
|
| Mitochondrial Diseases | 2 | 2006 | 132 | 0.110 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 111 | 0.110 |
Why?
|
| Algorithms | 3 | 2017 | 1633 | 0.110 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 51 | 0.110 |
Why?
|
| Prognosis | 8 | 2013 | 4686 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2014 | 145 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 62 | 0.110 |
Why?
|
| Respiratory Function Tests | 2 | 2011 | 198 | 0.110 |
Why?
|
| Animals | 27 | 2024 | 34318 | 0.110 |
Why?
|
| Urban Population | 2 | 2014 | 228 | 0.110 |
Why?
|
| Guinea Pigs | 2 | 1985 | 167 | 0.110 |
Why?
|
| Blood Urea Nitrogen | 2 | 2010 | 76 | 0.100 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2014 | 53 | 0.100 |
Why?
|
| Middle Aged | 22 | 2013 | 26765 | 0.100 |
Why?
|
| Linear Models | 2 | 2012 | 683 | 0.100 |
Why?
|
| Glutamate Decarboxylase | 1 | 2013 | 37 | 0.100 |
Why?
|
| Indomethacin | 3 | 2003 | 84 | 0.100 |
Why?
|
| Health Promotion | 1 | 2016 | 390 | 0.100 |
Why?
|
| Adiposity | 1 | 2014 | 190 | 0.100 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 78 | 0.100 |
Why?
|
| Adiponectin | 2 | 2011 | 113 | 0.100 |
Why?
|
| Carbon Isotopes | 3 | 2009 | 277 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 130 | 0.100 |
Why?
|
| Mexico | 5 | 1997 | 181 | 0.100 |
Why?
|
| Larynx | 1 | 2013 | 72 | 0.100 |
Why?
|
| C-Peptide | 1 | 2013 | 113 | 0.100 |
Why?
|
| Infant, Low Birth Weight | 5 | 2005 | 167 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2013 | 161 | 0.100 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2005 | 118 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 439 | 0.100 |
Why?
|
| Islets of Langerhans | 1 | 2013 | 174 | 0.100 |
Why?
|
| Nutritional Status | 2 | 2011 | 316 | 0.100 |
Why?
|
| Fractures, Spontaneous | 1 | 2012 | 18 | 0.100 |
Why?
|
| Critical Illness | 4 | 2001 | 600 | 0.090 |
Why?
|
| Heart Function Tests | 1 | 2011 | 58 | 0.090 |
Why?
|
| Sepsis | 6 | 2005 | 484 | 0.090 |
Why?
|
| Intestinal Absorption | 3 | 2005 | 191 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2013 | 133 | 0.090 |
Why?
|
| Lung | 2 | 2010 | 1491 | 0.090 |
Why?
|
| Echocardiography | 7 | 2011 | 1067 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 29 | 0.090 |
Why?
|
| Water Microbiology | 1 | 1991 | 25 | 0.090 |
Why?
|
| Primary Health Care | 2 | 2017 | 775 | 0.090 |
Why?
|
| Water Supply | 1 | 1991 | 26 | 0.090 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 860 | 0.090 |
Why?
|
| Meningitis, Haemophilus | 2 | 1988 | 34 | 0.090 |
Why?
|
| Lactulose | 3 | 1998 | 40 | 0.090 |
Why?
|
| Weight Reduction Programs | 1 | 2012 | 56 | 0.090 |
Why?
|
| Tracheostomy | 1 | 2013 | 196 | 0.090 |
Why?
|
| Skinfold Thickness | 5 | 2000 | 31 | 0.090 |
Why?
|
| Phytoestrogens | 1 | 2010 | 15 | 0.090 |
Why?
|
| Postoperative Complications | 6 | 2014 | 3056 | 0.090 |
Why?
|
| Cardiac Catheterization | 4 | 2011 | 633 | 0.090 |
Why?
|
| Risk | 4 | 2012 | 759 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1692 | 0.090 |
Why?
|
| Cardiac Output, Low | 2 | 2007 | 67 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 93 | 0.090 |
Why?
|
| Lung Diseases | 2 | 2010 | 385 | 0.090 |
Why?
|
| Intestines | 1 | 2014 | 577 | 0.090 |
Why?
|
| Heart Failure | 4 | 2009 | 2299 | 0.090 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2010 | 15 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2014 | 3313 | 0.090 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 15 | 0.090 |
Why?
|
| Mouth | 1 | 2011 | 62 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 855 | 0.080 |
Why?
|
| Hypertension | 6 | 2011 | 1332 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 53 | 0.080 |
Why?
|
| Emphysema | 1 | 2011 | 67 | 0.080 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 124 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 145 | 0.080 |
Why?
|
| Gastric Emptying | 1 | 2010 | 78 | 0.080 |
Why?
|
| Survival Analysis | 7 | 2014 | 1495 | 0.080 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 37 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2013 | 433 | 0.080 |
Why?
|
| Attitude to Health | 1 | 2011 | 257 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2011 | 190 | 0.080 |
Why?
|
| Heart Rate | 5 | 2007 | 592 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 774 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 141 | 0.080 |
Why?
|
| Prevalence | 4 | 2013 | 2467 | 0.080 |
Why?
|
| Positive-Pressure Respiration | 2 | 2001 | 84 | 0.080 |
Why?
|
| Respiration, Artificial | 4 | 2001 | 473 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 514 | 0.080 |
Why?
|
| Hypoxia | 2 | 1989 | 249 | 0.080 |
Why?
|
| beta-Fructofuranosidase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Statistics as Topic | 3 | 2004 | 257 | 0.080 |
Why?
|
| Behavior Therapy | 1 | 2012 | 256 | 0.080 |
Why?
|
| Facial Nerve Diseases | 1 | 2009 | 6 | 0.080 |
Why?
|
| Leptin | 5 | 2005 | 213 | 0.080 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2009 | 5 | 0.080 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 2009 | 19 | 0.080 |
Why?
|
| Retinoblastoma | 1 | 2010 | 111 | 0.080 |
Why?
|
| Sensitivity and Specificity | 7 | 2012 | 2056 | 0.080 |
Why?
|
| Sucrose | 1 | 2009 | 39 | 0.080 |
Why?
|
| Facial Paralysis | 1 | 2009 | 35 | 0.080 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2009 | 20 | 0.080 |
Why?
|
| Patient Compliance | 3 | 1997 | 471 | 0.080 |
Why?
|
| Body Height | 10 | 2000 | 216 | 0.080 |
Why?
|
| Neuroendocrine Cells | 1 | 2009 | 10 | 0.080 |
Why?
|
| Retinal Neoplasms | 1 | 2010 | 100 | 0.080 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 383 | 0.080 |
Why?
|
| Feces | 2 | 2010 | 727 | 0.080 |
Why?
|
| Defibrillators | 1 | 2009 | 21 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 187 | 0.080 |
Why?
|
| Osteomyelitis | 1 | 2012 | 209 | 0.080 |
Why?
|
| Hypolipidemic Agents | 2 | 2011 | 183 | 0.080 |
Why?
|
| Animal Feed | 2 | 2008 | 77 | 0.080 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2009 | 37 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2012 | 485 | 0.080 |
Why?
|
| Recurrence | 3 | 2010 | 1394 | 0.080 |
Why?
|
| Social Class | 3 | 2017 | 190 | 0.080 |
Why?
|
| Virus Activation | 2 | 2013 | 87 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 239 | 0.080 |
Why?
|
| Cytokines | 4 | 2014 | 1291 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2006 | 63 | 0.080 |
Why?
|
| Electric Countershock | 1 | 2009 | 67 | 0.080 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2018 | 120 | 0.070 |
Why?
|
| Moxalactam | 1 | 1988 | 21 | 0.070 |
Why?
|
| Chloramphenicol | 1 | 1988 | 28 | 0.070 |
Why?
|
| Models, Statistical | 3 | 2000 | 471 | 0.070 |
Why?
|
| Ampicillin | 1 | 1988 | 56 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2011 | 235 | 0.070 |
Why?
|
| Milk Substitutes | 1 | 2008 | 7 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 162 | 0.070 |
Why?
|
| Dogs | 3 | 2006 | 773 | 0.070 |
Why?
|
| DNA, Mitochondrial | 2 | 2006 | 212 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2009 | 90 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2010 | 495 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 1026 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 2009 | 199 | 0.070 |
Why?
|
| Vitamin D | 1 | 2009 | 165 | 0.070 |
Why?
|
| Calcium | 4 | 2009 | 1105 | 0.070 |
Why?
|
| Seizures | 2 | 2010 | 869 | 0.070 |
Why?
|
| Life Style | 2 | 2011 | 415 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2011 | 280 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 374 | 0.070 |
Why?
|
| Neutrophils | 3 | 2006 | 381 | 0.070 |
Why?
|
| Immunoassay | 3 | 2008 | 131 | 0.070 |
Why?
|
| Air Ambulances | 1 | 2007 | 24 | 0.070 |
Why?
|
| F2-Isoprostanes | 1 | 2007 | 20 | 0.070 |
Why?
|
| Logistic Models | 6 | 2017 | 1802 | 0.070 |
Why?
|
| Cachexia | 1 | 2007 | 48 | 0.070 |
Why?
|
| Heart Block | 1 | 2007 | 40 | 0.070 |
Why?
|
| Transportation of Patients | 1 | 2007 | 54 | 0.070 |
Why?
|
| Deuterium | 5 | 2003 | 109 | 0.070 |
Why?
|
| Heart Defects, Congenital | 3 | 2008 | 1832 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 1988 | 171 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 368 | 0.070 |
Why?
|
| Organ Size | 1 | 2008 | 442 | 0.070 |
Why?
|
| Myelin Sheath | 1 | 2007 | 122 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2009 | 243 | 0.070 |
Why?
|
| Brain | 3 | 2009 | 3014 | 0.070 |
Why?
|
| Gene Products, vpr | 1 | 2006 | 20 | 0.070 |
Why?
|
| Premature Birth | 1 | 2011 | 388 | 0.070 |
Why?
|
| Clinical Trials as Topic | 5 | 1993 | 1104 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 1988 | 139 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2014 | 1253 | 0.070 |
Why?
|
| Cardiomyopathies | 3 | 2007 | 500 | 0.060 |
Why?
|
| Diet, Fat-Restricted | 1 | 2006 | 40 | 0.060 |
Why?
|
| Ventricular Function | 1 | 2007 | 91 | 0.060 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 28 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1339 | 0.060 |
Why?
|
| Ultrasonography | 6 | 2013 | 939 | 0.060 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2007 | 118 | 0.060 |
Why?
|
| Hydrogen | 2 | 1985 | 41 | 0.060 |
Why?
|
| Catheterization | 2 | 2005 | 227 | 0.060 |
Why?
|
| Age of Onset | 4 | 2014 | 601 | 0.060 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 1985 | 74 | 0.060 |
Why?
|
| Pulmonary Surfactants | 2 | 1998 | 43 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 139 | 0.060 |
Why?
|
| Interleukin-6 | 3 | 2005 | 421 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2006 | 73 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2005 | 28 | 0.060 |
Why?
|
| Stroke Volume | 5 | 2011 | 496 | 0.060 |
Why?
|
| Rural Population | 4 | 1996 | 256 | 0.060 |
Why?
|
| Developmental Disabilities | 2 | 2007 | 715 | 0.060 |
Why?
|
| Helicobacter pylori | 2 | 1994 | 1324 | 0.060 |
Why?
|
| Multivariate Analysis | 7 | 2011 | 1427 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2010 | 303 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 170 | 0.060 |
Why?
|
| Helicobacter Infections | 2 | 1994 | 1267 | 0.060 |
Why?
|
| Tetrahydrofolates | 1 | 2005 | 17 | 0.060 |
Why?
|
| Insulin Infusion Systems | 1 | 2005 | 65 | 0.060 |
Why?
|
| Breeding | 2 | 1997 | 20 | 0.060 |
Why?
|
| Simethicone | 1 | 1985 | 3 | 0.060 |
Why?
|
| Quality of Life | 2 | 2013 | 1909 | 0.060 |
Why?
|
| Child Health Services | 2 | 2016 | 87 | 0.060 |
Why?
|
| Silicones | 1 | 1985 | 37 | 0.060 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2006 | 171 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2005 | 5 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2005 | 9 | 0.060 |
Why?
|
| Food, Fortified | 1 | 1985 | 96 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2005 | 94 | 0.060 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2004 | 10 | 0.060 |
Why?
|
| Platelet Transfusion | 1 | 2005 | 53 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2005 | 68 | 0.060 |
Why?
|
| Environment | 1 | 2005 | 142 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2006 | 144 | 0.060 |
Why?
|
| Digestion | 1 | 2005 | 41 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2011 | 862 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 262 | 0.060 |
Why?
|
| Incidence | 6 | 2012 | 3133 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2000 | 305 | 0.060 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2004 | 23 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2005 | 184 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 178 | 0.060 |
Why?
|
| Antigens | 1 | 2005 | 156 | 0.060 |
Why?
|
| Nutrition Surveys | 4 | 2011 | 295 | 0.060 |
Why?
|
| Developing Countries | 3 | 2014 | 271 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2009 | 4828 | 0.060 |
Why?
|
| Empyema, Pleural | 1 | 2004 | 25 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2009 | 356 | 0.060 |
Why?
|
| Adenoidectomy | 1 | 2005 | 76 | 0.060 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 21 | 0.060 |
Why?
|
| Axial Length, Eye | 1 | 2024 | 49 | 0.060 |
Why?
|
| Arginine Vasopressin | 1 | 2004 | 29 | 0.060 |
Why?
|
| Nerve Fibers | 1 | 2024 | 75 | 0.060 |
Why?
|
| Otitis Media with Effusion | 1 | 2004 | 18 | 0.060 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.050 |
Why?
|
| Infusions, Intravenous | 3 | 2017 | 554 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2004 | 55 | 0.050 |
Why?
|
| Neuromuscular Diseases | 1 | 2004 | 57 | 0.050 |
Why?
|
| Seasons | 2 | 2003 | 312 | 0.050 |
Why?
|
| Body Constitution | 3 | 1995 | 36 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2006 | 1240 | 0.050 |
Why?
|
| Macula Lutea | 1 | 2024 | 47 | 0.050 |
Why?
|
| Dietary Proteins | 3 | 2001 | 252 | 0.050 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2003 | 1 | 0.050 |
Why?
|
| Perfusion | 1 | 2005 | 206 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2000 | 391 | 0.050 |
Why?
|
| DNA, Viral | 3 | 2013 | 478 | 0.050 |
Why?
|
| Digoxin | 1 | 2003 | 43 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2004 | 374 | 0.050 |
Why?
|
| Tonsillectomy | 1 | 2005 | 99 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2010 | 1051 | 0.050 |
Why?
|
| JC Virus | 1 | 2003 | 30 | 0.050 |
Why?
|
| Propranolol | 1 | 2003 | 128 | 0.050 |
Why?
|
| Terbutaline | 2 | 1993 | 6 | 0.050 |
Why?
|
| Alleles | 1 | 2008 | 1618 | 0.050 |
Why?
|
| Virus Shedding | 1 | 2003 | 81 | 0.050 |
Why?
|
| Transposition of Great Vessels | 1 | 2004 | 132 | 0.050 |
Why?
|
| Intestinal Perforation | 1 | 2003 | 56 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 225 | 0.050 |
Why?
|
| Sex Factors | 5 | 2013 | 1275 | 0.050 |
Why?
|
| Myocardium | 1 | 2008 | 1022 | 0.050 |
Why?
|
| BK Virus | 1 | 2003 | 60 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 231 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 283 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2003 | 90 | 0.050 |
Why?
|
| Inflammation | 3 | 2006 | 1445 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 147 | 0.050 |
Why?
|
| Colon | 1 | 1985 | 352 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2016 | 440 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2005 | 367 | 0.050 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2003 | 109 | 0.050 |
Why?
|
| DiGeorge Syndrome | 1 | 2003 | 80 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2003 | 143 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 48 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2003 | 89 | 0.050 |
Why?
|
| Meningococcal Infections | 1 | 2002 | 19 | 0.050 |
Why?
|
| Rest | 2 | 1999 | 58 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2003 | 224 | 0.050 |
Why?
|
| Hypocotyl | 2 | 2012 | 6 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2004 | 275 | 0.050 |
Why?
|
| Computers | 2 | 1983 | 68 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2010 | 2880 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2005 | 1909 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 269 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2002 | 78 | 0.050 |
Why?
|
| Drug Therapy | 1 | 1982 | 87 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2005 | 205 | 0.050 |
Why?
|
| Postpericardiotomy Syndrome | 1 | 2001 | 4 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2001 | 36 | 0.050 |
Why?
|
| Premedication | 1 | 2001 | 41 | 0.050 |
Why?
|
| Neoplasms | 2 | 2013 | 2799 | 0.050 |
Why?
|
| Observer Variation | 3 | 2010 | 300 | 0.050 |
Why?
|
| Paracentesis | 1 | 2001 | 17 | 0.050 |
Why?
|
| Peritoneum | 1 | 2001 | 37 | 0.050 |
Why?
|
| Adolescent Health Services | 2 | 2000 | 36 | 0.040 |
Why?
|
| Lipids | 2 | 1998 | 522 | 0.040 |
Why?
|
| Pediatrics | 3 | 2017 | 1158 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2002 | 174 | 0.040 |
Why?
|
| Aftercare | 1 | 2002 | 147 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2001 | 105 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2001 | 93 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 1980 | 364 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2001 | 119 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 70 | 0.040 |
Why?
|
| Simplexvirus | 1 | 2001 | 104 | 0.040 |
Why?
|
| Parenteral Nutrition | 2 | 2001 | 196 | 0.040 |
Why?
|
| Rabbits | 2 | 2002 | 718 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 9058 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2002 | 479 | 0.040 |
Why?
|
| Leukocytes | 1 | 2002 | 212 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 545 | 0.040 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2000 | 21 | 0.040 |
Why?
|
| Hypoglycemia | 3 | 2008 | 192 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 339 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 730 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2000 | 63 | 0.040 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2000 | 59 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2001 | 51 | 0.040 |
Why?
|
| Food Deprivation | 1 | 2000 | 33 | 0.040 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2004 | 133 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2000 | 61 | 0.040 |
Why?
|
| Gene Expression | 2 | 2006 | 1554 | 0.040 |
Why?
|
| Butyrates | 1 | 2000 | 35 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 674 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2002 | 505 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2000 | 94 | 0.040 |
Why?
|
| Swine, Miniature | 2 | 1997 | 50 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 1999 | 9 | 0.040 |
Why?
|
| Drainage | 1 | 2001 | 260 | 0.040 |
Why?
|
| Plethysmography | 2 | 2010 | 35 | 0.040 |
Why?
|
| Mutation | 3 | 2008 | 5904 | 0.040 |
Why?
|
| Space Flight | 1 | 2001 | 107 | 0.040 |
Why?
|
| Respiration | 3 | 2003 | 122 | 0.040 |
Why?
|
| X Chromosome | 1 | 2000 | 338 | 0.040 |
Why?
|
| Hyaline Membrane Disease | 1 | 1998 | 4 | 0.040 |
Why?
|
| Carbon Dioxide | 4 | 2009 | 279 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2001 | 354 | 0.040 |
Why?
|
| Soybean Proteins | 1 | 1998 | 17 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 351 | 0.040 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1998 | 27 | 0.040 |
Why?
|
| Fats | 3 | 1988 | 12 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 1998 | 47 | 0.040 |
Why?
|
| Mannitol | 1 | 1998 | 49 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2000 | 193 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 176 | 0.040 |
Why?
|
| Azathioprine | 1 | 1998 | 54 | 0.040 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1998 | 37 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2000 | 272 | 0.040 |
Why?
|
| Exercise Test | 2 | 2011 | 254 | 0.040 |
Why?
|
| Permeability | 1 | 1998 | 124 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 1999 | 217 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 3 | 1989 | 43 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 256 | 0.040 |
Why?
|
| Iodocyanopindolol | 1 | 1997 | 3 | 0.040 |
Why?
|
| Hormones | 1 | 1999 | 186 | 0.040 |
Why?
|
| Growth Disorders | 2 | 1992 | 209 | 0.040 |
Why?
|
| Pindolol | 1 | 1997 | 8 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2016 | 265 | 0.040 |
Why?
|
| Nervous System | 1 | 1998 | 128 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4409 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2011 | 586 | 0.040 |
Why?
|
| Cyclosporine | 1 | 1998 | 145 | 0.040 |
Why?
|
| Prednisone | 1 | 1998 | 278 | 0.040 |
Why?
|
| Medical Records | 2 | 2009 | 191 | 0.040 |
Why?
|
| Fasting | 1 | 1999 | 293 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2001 | 768 | 0.030 |
Why?
|
| Medroxyprogesterone | 1 | 1997 | 8 | 0.030 |
Why?
|
| Peru | 3 | 1994 | 47 | 0.030 |
Why?
|
| Amenorrhea | 1 | 1997 | 20 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2000 | 414 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 1997 | 37 | 0.030 |
Why?
|
| Weight Loss | 3 | 2005 | 482 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 60 | 0.030 |
Why?
|
| Mucositis | 1 | 2017 | 19 | 0.030 |
Why?
|
| Privacy | 1 | 1997 | 26 | 0.030 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1997 | 98 | 0.030 |
Why?
|
| Mitral Valve | 2 | 2011 | 252 | 0.030 |
Why?
|
| Family Practice | 1 | 1997 | 91 | 0.030 |
Why?
|
| Hypothalamic Diseases | 1 | 1997 | 37 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 1998 | 185 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 945 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2001 | 688 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2004 | 282 | 0.030 |
Why?
|
| Directly Observed Therapy | 1 | 2016 | 25 | 0.030 |
Why?
|
| Aged | 8 | 2011 | 19727 | 0.030 |
Why?
|
| Length of Stay | 2 | 2004 | 1310 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 1998 | 230 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 668 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1998 | 301 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 318 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2017 | 129 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3603 | 0.030 |
Why?
|
| Isoniazid | 1 | 2016 | 62 | 0.030 |
Why?
|
| Random Allocation | 2 | 1988 | 439 | 0.030 |
Why?
|
| Probability | 2 | 2010 | 318 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 1997 | 373 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 1997 | 185 | 0.030 |
Why?
|
| Rifampin | 1 | 2016 | 131 | 0.030 |
Why?
|
| Tuberculin Test | 1 | 2016 | 123 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2008 | 430 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2009 | 1065 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2017 | 171 | 0.030 |
Why?
|
| Triglycerides | 2 | 2011 | 576 | 0.030 |
Why?
|
| Equipment Design | 2 | 2009 | 589 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2003 | 3044 | 0.030 |
Why?
|
| Angioplasty, Balloon | 1 | 1996 | 155 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 1996 | 110 | 0.030 |
Why?
|
| Biopsy | 2 | 2009 | 1244 | 0.030 |
Why?
|
| Creatinine | 2 | 2007 | 394 | 0.030 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2016 | 174 | 0.030 |
Why?
|
| Fetus | 2 | 1992 | 586 | 0.030 |
Why?
|
| Platelet Count | 2 | 2005 | 137 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 1006 | 0.030 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 34 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2009 | 459 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 1720 | 0.030 |
Why?
|
| Isoproterenol | 2 | 2000 | 106 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1997 | 316 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 2016 | 252 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 645 | 0.030 |
Why?
|
| United States | 5 | 2011 | 10908 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 127 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 1997 | 290 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 40 | 0.030 |
Why?
|
| Heroin Dependence | 2 | 1985 | 56 | 0.030 |
Why?
|
| Survival Rate | 2 | 2009 | 2050 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 60 | 0.030 |
Why?
|
| Infliximab | 1 | 2014 | 66 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 1998 | 338 | 0.030 |
Why?
|
| Cholestasis | 2 | 2005 | 155 | 0.030 |
Why?
|
| Colectomy | 1 | 2014 | 74 | 0.030 |
Why?
|
| Fatty Alcohols | 1 | 1993 | 5 | 0.030 |
Why?
|
| Myocarditis | 1 | 1995 | 130 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2013 | 3431 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 1993 | 26 | 0.030 |
Why?
|
| Haemophilus influenzae | 3 | 1988 | 130 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2013 | 11 | 0.030 |
Why?
|
| Accelerometry | 1 | 2013 | 60 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 1997 | 429 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 1993 | 33 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2014 | 92 | 0.030 |
Why?
|
| Pulmonary Alveoli | 2 | 2010 | 134 | 0.030 |
Why?
|
| Parents | 2 | 2017 | 1023 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2008 | 496 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2012 | 7 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1993 | 75 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 1707 | 0.030 |
Why?
|
| Fetal Movement | 1 | 1992 | 14 | 0.030 |
Why?
|
| Airway Obstruction | 2 | 2011 | 165 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 375 | 0.030 |
Why?
|
| Tocolytic Agents | 1 | 1992 | 12 | 0.030 |
Why?
|
| Malawi | 1 | 2014 | 398 | 0.020 |
Why?
|
| Lactation Disorders | 1 | 1992 | 3 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1993 | 150 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 383 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 1997 | 399 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 1993 | 189 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 3 | 1991 | 113 | 0.020 |
Why?
|
| Lipoprotein Lipase | 2 | 2003 | 56 | 0.020 |
Why?
|
| Diarrhea, Infantile | 2 | 1982 | 35 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1550 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 682 | 0.020 |
Why?
|
| Smoking | 2 | 2011 | 1048 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 526 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 880 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 2061 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 780 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 57 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 240 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 601 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1985 | 229 | 0.020 |
Why?
|
| Behavior | 1 | 2011 | 73 | 0.020 |
Why?
|
| Syndrome | 2 | 2012 | 1121 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1997 | 675 | 0.020 |
Why?
|
| Dancing | 1 | 1991 | 9 | 0.020 |
Why?
|
| Mesalamine | 1 | 2011 | 5 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1991 | 71 | 0.020 |
Why?
|
| Age Distribution | 2 | 2004 | 418 | 0.020 |
Why?
|
| Glucose | 2 | 2009 | 878 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2006 | 4423 | 0.020 |
Why?
|
| Housing | 1 | 1991 | 59 | 0.020 |
Why?
|
| Mathematics | 3 | 1988 | 97 | 0.020 |
Why?
|
| Cricetinae | 2 | 2009 | 422 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 621 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2012 | 223 | 0.020 |
Why?
|
| Urine | 3 | 2003 | 91 | 0.020 |
Why?
|
| Bronchi | 1 | 2011 | 99 | 0.020 |
Why?
|
| Sheep | 2 | 1988 | 219 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2011 | 90 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 338 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1997 | 617 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2010 | 14 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 2010 | 28 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1998 | 1172 | 0.020 |
Why?
|
| Acute Disease | 2 | 2012 | 1097 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 280 | 0.020 |
Why?
|
| Saliva | 3 | 2003 | 114 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 287 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2010 | 29 | 0.020 |
Why?
|
| Activin Receptors, Type II | 1 | 2010 | 31 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 433 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1988 | 250 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 36 | 0.020 |
Why?
|
| Steroids | 1 | 2011 | 202 | 0.020 |
Why?
|
| Kidney | 2 | 2007 | 1363 | 0.020 |
Why?
|
| Species Specificity | 2 | 2005 | 551 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 97 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 283 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1244 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2011 | 173 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2010 | 88 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2010 | 100 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 649 | 0.020 |
Why?
|
| Synkinesis | 1 | 2009 | 2 | 0.020 |
Why?
|
| Smiling | 1 | 2009 | 4 | 0.020 |
Why?
|
| Sucrase | 1 | 2009 | 22 | 0.020 |
Why?
|
| Facial Asymmetry | 1 | 2009 | 17 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1399 | 0.020 |
Why?
|
| Electrocardiography | 1 | 1995 | 978 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 2813 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 198 | 0.020 |
Why?
|
| Biogenic Amines | 1 | 1989 | 20 | 0.020 |
Why?
|
| Cognition | 2 | 2012 | 722 | 0.020 |
Why?
|
| Muramidase | 3 | 1984 | 94 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1269 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2009 | 72 | 0.020 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2010 | 90 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 363 | 0.020 |
Why?
|
| Nutrition Disorders | 3 | 1987 | 32 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 304 | 0.020 |
Why?
|
| Base Sequence | 2 | 2003 | 3111 | 0.020 |
Why?
|
| Ammonia | 1 | 1989 | 76 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 442 | 0.020 |
Why?
|
| CpG Islands | 1 | 2010 | 329 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2008 | 72 | 0.020 |
Why?
|
| Endorphins | 1 | 1988 | 7 | 0.020 |
Why?
|
| Medicaid | 1 | 2011 | 242 | 0.020 |
Why?
|
| Disease Progression | 2 | 2009 | 2084 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2009 | 200 | 0.020 |
Why?
|
| Lactoferrin | 3 | 1984 | 78 | 0.020 |
Why?
|
| Neurocognitive Disorders | 1 | 1989 | 68 | 0.020 |
Why?
|
| Phosphorus | 2 | 1985 | 58 | 0.020 |
Why?
|
| Phenotype | 2 | 2013 | 4270 | 0.020 |
Why?
|
| Thermodilution | 1 | 1988 | 11 | 0.020 |
Why?
|
| Mice | 4 | 2006 | 17750 | 0.020 |
Why?
|
| Indicator Dilution Techniques | 1 | 1988 | 25 | 0.020 |
Why?
|
| Bradycardia | 1 | 1988 | 60 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1989 | 211 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 1988 | 22 | 0.020 |
Why?
|
| Nitroprusside | 1 | 1988 | 42 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 281 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 190 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 280 | 0.020 |
Why?
|
| Manikins | 1 | 2009 | 136 | 0.020 |
Why?
|
| Video Recording | 1 | 2009 | 183 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 408 | 0.020 |
Why?
|
| Dobutamine | 1 | 1987 | 56 | 0.020 |
Why?
|
| Aldosterone | 1 | 2007 | 61 | 0.020 |
Why?
|
| Body Fluids | 1 | 1988 | 47 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2007 | 41 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1987 | 248 | 0.020 |
Why?
|
| Hypotension | 1 | 2009 | 186 | 0.020 |
Why?
|
| Diuresis | 1 | 2007 | 58 | 0.020 |
Why?
|
| Renin | 1 | 2007 | 93 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 228 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1988 | 91 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 2007 | 41 | 0.020 |
Why?
|
| Meningitis | 1 | 1988 | 98 | 0.020 |
Why?
|
| Language Development | 1 | 2007 | 33 | 0.020 |
Why?
|
| Actuarial Analysis | 2 | 1988 | 33 | 0.020 |
Why?
|
| Dinoprost | 1 | 2007 | 28 | 0.020 |
Why?
|
| Acidosis | 1 | 1988 | 93 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2003 | 2603 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 176 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 79 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 1998 | 231 | 0.020 |
Why?
|
| Sodium | 2 | 1985 | 299 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 1988 | 130 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2008 | 335 | 0.020 |
Why?
|
| Time | 1 | 2007 | 92 | 0.020 |
Why?
|
| Trace Elements | 1 | 1987 | 27 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2009 | 190 | 0.020 |
Why?
|
| Paresis | 1 | 1986 | 35 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2008 | 227 | 0.020 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 13 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 62 | 0.020 |
Why?
|
| Electrolytes | 1 | 2006 | 53 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 3 | 2004 | 2430 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2011 | 403 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1703 | 0.020 |
Why?
|
| Methadone | 2 | 1985 | 125 | 0.020 |
Why?
|
| Dopamine | 1 | 1987 | 282 | 0.020 |
Why?
|
| Deafness | 1 | 1986 | 82 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 309 | 0.020 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2005 | 5 | 0.020 |
Why?
|
| Cineangiography | 1 | 2005 | 16 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1985 | 14 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2005 | 121 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2007 | 783 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 2 | 2004 | 376 | 0.020 |
Why?
|
| Suction | 1 | 1985 | 55 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 1985 | 34 | 0.020 |
Why?
|
| HIV Infections | 2 | 1998 | 1896 | 0.020 |
Why?
|
| Home Nursing | 1 | 1985 | 16 | 0.020 |
Why?
|
| Magnesium | 1 | 1985 | 123 | 0.020 |
Why?
|
| Microspheres | 1 | 2005 | 70 | 0.020 |
Why?
|
| Leucovorin | 1 | 2005 | 49 | 0.020 |
Why?
|
| Tablets | 1 | 1985 | 27 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 1988 | 241 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1592 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2006 | 404 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 296 | 0.010 |
Why?
|
| Folic Acid Deficiency | 1 | 2005 | 53 | 0.010 |
Why?
|
| Oxygen Isotopes | 3 | 1991 | 35 | 0.010 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2005 | 122 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 6560 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 532 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 125 | 0.010 |
Why?
|
| Vital Capacity | 1 | 2005 | 76 | 0.010 |
Why?
|
| Milk | 1 | 1985 | 119 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 1985 | 61 | 0.010 |
Why?
|
| Electron Transport | 1 | 2004 | 55 | 0.010 |
Why?
|
| Mucins | 1 | 2005 | 75 | 0.010 |
Why?
|
| Placenta | 1 | 2009 | 508 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 55 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 28 | 0.010 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 22 | 0.010 |
Why?
|
| Cattle | 1 | 1985 | 567 | 0.010 |
Why?
|
| Short Bowel Syndrome | 1 | 2005 | 66 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 143 | 0.010 |
Why?
|
| Intelligence | 1 | 1985 | 100 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2005 | 210 | 0.010 |
Why?
|
| Head | 1 | 1985 | 104 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 464 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 41 | 0.010 |
Why?
|
| Breast | 1 | 1985 | 213 | 0.010 |
Why?
|
| Polysomnography | 1 | 2005 | 145 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 887 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 262 | 0.010 |
Why?
|
| Azo Compounds | 1 | 2003 | 8 | 0.010 |
Why?
|
| Isomerism | 1 | 2003 | 31 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2004 | 75 | 0.010 |
Why?
|
| Laparotomy | 1 | 2005 | 135 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 605 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 165 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2004 | 89 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 680 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2004 | 121 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 78 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1983 | 99 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 2003 | 13 | 0.010 |
Why?
|
| Galactosidases | 1 | 1983 | 7 | 0.010 |
Why?
|
| Ligation | 1 | 2003 | 133 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 92 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2004 | 244 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2003 | 57 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 2003 | 41 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1756 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2096 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2003 | 118 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 825 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2003 | 91 | 0.010 |
Why?
|
| HIV-1 | 1 | 2006 | 464 | 0.010 |
Why?
|
| Diet Surveys | 1 | 1983 | 98 | 0.010 |
Why?
|
| Unemployment | 1 | 1982 | 20 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 1153 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 276 | 0.010 |
Why?
|
| Antarctic Regions | 1 | 2002 | 23 | 0.010 |
Why?
|
| Ireland | 1 | 2002 | 28 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 384 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1982 | 52 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 377 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1982 | 85 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 2002 | 49 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 574 | 0.010 |
Why?
|
| L-Selectin | 1 | 2002 | 22 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1983 | 207 | 0.010 |
Why?
|
| Serotyping | 1 | 2002 | 178 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 325 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 54 | 0.010 |
Why?
|
| Malabsorption Syndromes | 1 | 1982 | 36 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2002 | 116 | 0.010 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2002 | 43 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 142 | 0.010 |
Why?
|
| Pericardiocentesis | 1 | 2001 | 16 | 0.010 |
Why?
|
| Educational Status | 1 | 1982 | 275 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2004 | 365 | 0.010 |
Why?
|
| Microscopy | 1 | 2002 | 119 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 295 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 830 | 0.010 |
Why?
|
| Pressure | 1 | 2001 | 128 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2002 | 347 | 0.010 |
Why?
|
| Solubility | 1 | 2001 | 139 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2000 | 89 | 0.010 |
Why?
|
| Drug Utilization | 1 | 1982 | 161 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2004 | 438 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 2414 | 0.010 |
Why?
|
| Fatty Acid Synthases | 1 | 2000 | 11 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2000 | 19 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2000 | 13 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2000 | 41 | 0.010 |
Why?
|
| Homeostasis | 1 | 1985 | 705 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 463 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 376 | 0.010 |
Why?
|
| Sterol Esterase | 1 | 2000 | 19 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 25 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2000 | 17 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 374 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2000 | 33 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2000 | 41 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 28 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2000 | 68 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2000 | 66 | 0.010 |
Why?
|
| Diastole | 2 | 1993 | 178 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 61 | 0.010 |
Why?
|
| Postprandial Period | 1 | 2000 | 77 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 1983 | 262 | 0.010 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2000 | 76 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 273 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2007 | 828 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2001 | 140 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2001 | 248 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1077 | 0.010 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 1982 | 260 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 1749 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1982 | 396 | 0.010 |
Why?
|
| Erythema Multiforme | 1 | 1998 | 2 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 521 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2009 | 1183 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1998 | 37 | 0.010 |
Why?
|
| Hematocrit | 1 | 1998 | 114 | 0.010 |
Why?
|
| Hydrops Fetalis | 1 | 1998 | 74 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 706 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1983 | 515 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 473 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 605 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 471 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 810 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3900 | 0.010 |
Why?
|
| Bilirubin | 1 | 1998 | 125 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1998 | 175 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1998 | 316 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 345 | 0.010 |
Why?
|
| Managed Care Programs | 1 | 1997 | 61 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1997 | 98 | 0.010 |
Why?
|
| Professional Practice Location | 1 | 1996 | 7 | 0.010 |
Why?
|
| Neonatology | 1 | 1997 | 53 | 0.010 |
Why?
|
| Pedigree | 1 | 2000 | 1610 | 0.010 |
Why?
|
| Health Resources | 1 | 1997 | 116 | 0.010 |
Why?
|
| Life Tables | 1 | 1995 | 28 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1988 | 257 | 0.010 |
Why?
|
| Hospital Costs | 1 | 1997 | 179 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2000 | 879 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1994 | 71 | 0.010 |
Why?
|
| Pneumonia | 1 | 1998 | 325 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1998 | 675 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1997 | 372 | 0.010 |
Why?
|
| Urea | 1 | 1994 | 231 | 0.010 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 1984 | 20 | 0.010 |
Why?
|
| Syringes | 1 | 1993 | 25 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1993 | 108 | 0.010 |
Why?
|
| Zidovudine | 1 | 1993 | 23 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1995 | 198 | 0.010 |
Why?
|
| Milk Proteins | 2 | 1984 | 92 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1993 | 65 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1993 | 149 | 0.010 |
Why?
|
| Critical Care | 1 | 1998 | 656 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 1961 | 0.010 |
Why?
|
| Systole | 1 | 1993 | 201 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1992 | 163 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1993 | 102 | 0.010 |
Why?
|
| Morbidity | 1 | 1993 | 248 | 0.010 |
Why?
|
| Glutathione | 1 | 1993 | 196 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1993 | 240 | 0.010 |
Why?
|
| Anorexia Nervosa | 1 | 1991 | 24 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1991 | 59 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 1654 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1995 | 531 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1991 | 153 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 1243 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 1990 | 40 | 0.010 |
Why?
|
| Neopterin | 1 | 1989 | 3 | 0.000 |
Why?
|
| Dihydropteridine Reductase | 1 | 1989 | 5 | 0.000 |
Why?
|
| Emergency Service, Hospital | 2 | 1988 | 1068 | 0.000 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1989 | 59 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1989 | 126 | 0.000 |
Why?
|
| Hydrochloric Acid | 1 | 1988 | 14 | 0.000 |
Why?
|
| Asphyxia Neonatorum | 1 | 1988 | 15 | 0.000 |
Why?
|
| Naloxone | 1 | 1988 | 48 | 0.000 |
Why?
|
| Neisseria meningitidis | 1 | 1988 | 19 | 0.000 |
Why?
|
| Body Fluid Compartments | 1 | 1988 | 19 | 0.000 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1993 | 972 | 0.000 |
Why?
|
| Plasma | 1 | 1988 | 99 | 0.000 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1986 | 22 | 0.000 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1987 | 93 | 0.000 |
Why?
|
| Rats | 1 | 1993 | 3729 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1986 | 90 | 0.000 |
Why?
|
| Follicular Phase | 1 | 1985 | 15 | 0.000 |
Why?
|
| Focal Infection | 1 | 1985 | 3 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1988 | 307 | 0.000 |
Why?
|
| Body Surface Area | 1 | 1985 | 31 | 0.000 |
Why?
|
| Ventilators, Mechanical | 1 | 1985 | 40 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 143 | 0.000 |
Why?
|
| Cephalometry | 1 | 1985 | 33 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1989 | 849 | 0.000 |
Why?
|
| Centrifugation | 1 | 1984 | 25 | 0.000 |
Why?
|
| Organization and Administration | 1 | 1983 | 4 | 0.000 |
Why?
|
| Libraries | 1 | 1983 | 3 | 0.000 |
Why?
|
| Quality Control | 1 | 1983 | 121 | 0.000 |
Why?
|
| Methods | 1 | 1983 | 149 | 0.000 |
Why?
|
| Chromatography, Gas | 1 | 1983 | 31 | 0.000 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1983 | 133 | 0.000 |
Why?
|
| Nutritive Value | 1 | 1983 | 92 | 0.000 |
Why?
|
| Fever | 1 | 1985 | 300 | 0.000 |
Why?
|
| Antigens, Bacterial | 1 | 1984 | 314 | 0.000 |
Why?
|
| Zinc | 1 | 1983 | 135 | 0.000 |
Why?
|
| Prenatal Care | 1 | 1985 | 348 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1985 | 391 | 0.000 |
Why?
|
| Hypothermia | 1 | 1982 | 57 | 0.000 |
Why?
|
| Kinetics | 1 | 1983 | 1333 | 0.000 |
Why?
|
| History, 20th Century | 1 | 1983 | 384 | 0.000 |
Why?
|
| Iron | 1 | 1983 | 277 | 0.000 |
Why?
|